Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients (Q40850644)

24 September 2017

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

1 reference

Ikeda K

1

1 reference

24 September 2017

Saitoh S

2

1 reference

24 September 2017

Suzuki Y

3

1 reference

24 September 2017

Kobayashi M

4

1 reference

24 September 2017

Tsubota A

5

1 reference

24 September 2017

Koida I

6

1 reference

24 September 2017

Arase Y

7

1 reference

24 September 2017

Fukuda M

8

1 reference

24 September 2017

Chayama K

9

1 reference

24 September 2017

Murashima N

10

1 reference

24 September 2017

Kumada H

11

1 reference

24 September 2017

1 June 1998

1 reference

24 September 2017

Journal of Hepatology

1 reference

24 September 2017

28

1 reference

24 September 2017

930-938

1 reference

24 September 2017

6

1 reference

A case/control study of the association between primary liver cancer and hepatitis b infection in senegal

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis C-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Review of hepatitis C in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Relationship between hepatocellular carcinoma and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Early recognition of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis. A cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Natural history and prognostic factors for chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus–related chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Antiviral therapy of hepatitis C--present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980339-5

7 January 2021

10.1016/S0168-8278(98)80339-5

Identifiers

DOI

1 reference

24 September 2017

1 reference